Thrivent Financial for Lutherans Has $240.33 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Thrivent Financial for Lutherans increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.5% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 442,483 shares of the medical equipment provider’s stock after buying an additional 103,364 shares during the period. Intuitive Surgical makes up 0.5% of Thrivent Financial for Lutherans’ holdings, making the stock its 22nd biggest holding. Thrivent Financial for Lutherans’ holdings in Intuitive Surgical were worth $240,329,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Tobam grew its stake in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth $27,000. TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the last quarter. 1248 Management LLC bought a new position in Intuitive Surgical in the 1st quarter valued at $30,000. Finally, Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $542.32 on Friday. The company has a market capitalization of $194.41 billion, a price-to-earnings ratio of 71.74, a P/E/G ratio of 4.98 and a beta of 1.68. The firm’s 50 day simple moving average is $529.62 and its 200 day simple moving average is $505.69. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.84 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 28,800 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the sale, the insider owned 27,027 shares in the company, valued at $14,798,904.12. This represents a 51.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Edward Miller sold 3,500 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the sale, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. The trade was a 37.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 109,043 shares of company stock worth $60,816,225 over the last ninety days. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on ISRG shares. Citigroup cut Intuitive Surgical from a “buy” rating to a “neutral” rating and decreased their price target for the company from $650.00 to $635.00 in a report on Thursday. Rothschild & Co Redburn upped their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Argus increased their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $608.79.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.